Last reviewed · How we verify

NCT04932486

Transcutaneous Electrical Stimulation in Obstructive Sleep Apnea

Completed NA Last updated 14 April 2023
What this trial tests

NA trial testing Transcutaneous electrical stimulation in Obstructive Sleep Apnea in 42 participants. Completed in 13 April 2023.

Timeline
26 May 2021
Primary endpoint
13 April 2023
13 April 2023

Quick facts

Lead sponsorSunrise
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment42
Start date26 May 2021
Primary completion13 April 2023
Estimated completion13 April 2023
Sites1 location across Belgium

Drugs / interventions tested

Conditions studied

Sponsor

Sunrise — full company profile →

Who can join

18 and older, any sex, with Obstructive Sleep Apnea. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to assess the efficacy of transcutaneous electrical stimulation of the upper airway muscles in patients with obstructive sleep apnea.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Transcutaneous electrical stimulation

Trials testing the same drug.

Other recruiting trials for Obstructive Sleep Apnea

Currently open trials in the same condition.

Other Sunrise trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04932486.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing